Dose-dense FEC followed by docetaxel versus docetaxel plus cyclophosphamide as adjuvant chemotherapy in women with HER2-negative, axillary lymph node-positive early breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG)
Titel:
Dose-dense FEC followed by docetaxel versus docetaxel plus cyclophosphamide as adjuvant chemotherapy in women with HER2-negative, axillary lymph node-positive early breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG)
Auteur:
Mavroudis, D. Matikas, A. Malamos, N. Papakotoulas, P. Kakolyris, S. Boukovinas, I. Athanasiadis, A. Kentepozidis, N. Ziras, N. Katsaounis, P. Saloustros, E. Georgoulias, V.